Trial Profile
The Assessment of Osteoporosis Treatment in Post-menopausal Women
Status:
Not stated
Phase of Trial:
Phase IV
Latest Information Update: 07 Dec 2021
Price :
$35
*
At a glance
- Drugs Raloxifene (Primary) ; Alendronic acid/colecalciferol
- Indications Depressive disorders; Postmenopausal osteoporosis
- Focus Pharmacodynamics
- 11 Jan 2019 Status changed from not yet recruiting to recruiting.
- 02 Jan 2017 New trial record